Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.

Biotechnology

Mnemo Therapeutics

Robert Lacaze

Ikram H.

Theodoros Giavridis

Michael Saitakis

Nil Ege

Bertrand Vannier

Justin Eyquem

Bénédicte Balland

Christine Foster

Nadia Kaci-Chaouche

Alain Maiore

Mariana Gajardo

The leaders of Mnemo Therapeutics have a long history of experience in the field of cancer research and treatment. They have worked at some of the biggest names in the industry, including Johnson & Johnson, Novartis, and UCSF. They have also been involved in groundbreaking research projects at renowned institutes such as MIT and Memorial Sloan Kettering. This wealth of experience and knowledge gives Mnemo Therapeutics a unique perspective on the challenges facing cancer patients today.

Leadership Team

Board of Directors

Founding Team

Leadership Team

About

Team members

Other teams at Mnemo Therapeutics

Board of Directors

Founding Team